The primary goal of this study was to identify the global impact of HNRNPA2/B1 overexpression on the miRNA transcriptome of luminal A MCF-7 breast cancer cells, based on the observation of higher HNRNPA2/B1 in LCC9 endocrine-resistant breast cancer cells. This evidence concerns the gene HNRNPA2B1 and breast cancer.